Affibody has a strong IP position with several granted patents on the basic technology. We have a comprehensive patent portfolio in the area of protein engineering technologies, covering: 

• The Affibody® class of molecules
• Composition for Affibody® molecules specific to targets
• The Albumod™ platform
• The alkaline stabilization technology

Affibody® molecule patents do not overlap with conventional aptamer, monoclonal and domain antibody patents.